Skip to main content

Animations

MJFF Publications

2661 - 2670 of 9104 Results
Title
Year
  • Year
  • 2018
  • 2010
  • 2016
  • 2017
  • 2009
  • 2009
  • 2009
  • 2013
  • 2011
  • 2017
  • Summary Details
    OPEN
    Title: Downregulation of tyrosine hydroxylase phenotype after AAV injection above substantia nigra: Caution in experimental models of Parkinson’s disease
    Journal Name: Journal of Neuroscience Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/jnr.24363
    Citation Count: 33
  • Summary Details
    OPEN
    Title: 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1042/bj20100483
    Citation Count: 405
  • Summary Details
    RESTRICTED
    Title: Non-radioactive in vitro PINK1 Kinase Assays Using Ubiquitin or Parkin as Substrate
    Journal Name: BIO-PROTOCOL
    Publisher: Bio-Protocol, LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.21769/bioprotoc.1946
    Citation Count: 7
  • Summary Details
    OPEN
    Title: The G2385R risk factor for Parkinson's disease enhances CHIP-dependent intracellular degradation of LRRK2
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1042/bcj20160909
    Citation Count: 39
  • Summary Details
    OPEN
    Title: Elevated Serum Pesticide Levels and Risk of Parkinson Disease
    Journal Name: Archives of Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/archneurol.2009.89
    Citation Count: 135
  • Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum
    2009
    Summary Details
    RESTRICTED
    Title: Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum
    Journal Name: Biochemical and Biophysical Research Communications
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbrc.2009.10.045
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1042/bj20091035
    Citation Count: 203
  • Summary Details
    RESTRICTED
    Title: Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1042/bj20121772
    Citation Count: 97
  • Summary Details
    OPEN
    Title: S-Nitrosylation of ApoE in Alzheimer’s Disease
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/bi200266v
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Tissue-specific network-based genome wide study of amygdala imaging phenotypes to identify functional interaction modules
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btx344
    Citation Count: 25
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.